Skip to search formSkip to main contentSkip to account menu

GSK1325756

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

PiperidinesSulfones

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Identification and characterisation of a salt form of Danirixin with reduced pharmacokinetic variability in patient populations
2017
2017
Late Breaking Abstract - Danirixin (GSK1325756) improves respiratory symptoms and health status in mild to moderate COPD – results of a 1 year first time in patient study
Background: Danirixin (DNX) is a competitive, reversible CXCR2 chemokine receptor antagonist. CXCR2 antagonists inhibit… 
2013
2013
Assessment of potential drug interactions by characterization of human drug metabolism pathways using non‐invasive bile sampling
Characterization of the biliary disposition of GSK1325756, using a non‐invasive bile sampling technique and spectrometric… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)